Search Results

The Privacy Policy of Clinical Diagnostic Laboratories located in Sterling and Ashburn is located on this page. Privacy Statement 1. Introduction Welcome to Clinical Diagnostic Laboratories ("we," "us," or "our"). This Privacy Statement outlines how we collect, use, disclose, and safeguard your personal and medical information when you use our services, including our website and related applications (collectively referred to as the "Services"). By using our Services, you consent to the practices described in this Privacy Statement. 2. Information We Collect We may collect various types o f information from you, including: Personal Information: Name, contact information, date of birth, and other relevant identifiers. Medical Information: Information related to your health, medical history, and test results. Payment Information: Payment details for services purchased through our platform. Usage Data: Information about how you use our Services, including website interactions and app usage. 3. How We Use You r Infor mation We use the collected information for the following purposes: Providing Services: To deliver and manage the diagnostic testing services you request, including appointment scheduling and test result delivery. Communication: To contact you regarding appointments, test results, billing, and other relevant matters. Improving Services: To enhance and customize your experience with our Services, and to develop new features and offerings. Legal and Regulatory Compliance: To comply with applicable laws, regulations, and legal processes. 4. Information Sharing We may share your information with: Healthcare Providers: To facilitate the interpretation and communication of test results by qualified medical professionals. Service Providers: Third-party vendors and partners who assist us in providing and maintaining our Services. Legal Authorities: When req uired by law or in response to legal requests, such as court orders or subpoenas. 5. Data Security We implement appropriate technical and organizational measures to safeguard your personal and medical information. However, no data transmission over the Internet is completely secure, and we cannot guarantee the absolute security of your information. 6. Your Choices Access and Correction: You may review, update, or correct your personal information by contacting us. Communications: You can choose to receive or opt out of certain communications from us. Cookies and Tracking: You can manage your cookie preferences through your browser settings. 7. Third-Party Links Our Services may contain links to third-party websites. We are not responsible for the privacy practices or content of these websites. Please review the privacy policies of third-party sites before providing any personal information. 8. Children's Privacy Our Services are not intended for individuals un der the age of 18. We do not knowingly collect personal information from children. 9. Changes to this Privacy Statement We may update this Privacy Statement to reflect changes in our practices or legal requirements. Any changes will be posted on our website, and the date of the latest revision will be indicated. 10. Contact Us If you have questions, concerns, or requests related to your privacy or this Privacy Statement, please contact us at: Clinical Diagnostic Laboratories 2 Pidgeon Hill Dr., Suite 150, Sterling, VA 20165 44355 Premier Plaza, Suite 240, Ashburn, VA 20147 Email: info@clinicaldiagnosticlab.com Phone: (703) 430-1111 Fax: (703) 722-3890

Ordering information regarding a Tryptase test for Clinical Diagnostic Laboratories. SARS-CoV-2 (COVID-19) Ordering Recommendation Use to detect the novel coronavirus (SARS-CoV-2). Mnemonic Methodology Qualitative Nucleic Acid Amplification (NAA) Performed Mon-Sat Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Nasopharyngeal swab, oropharyngeal swab, nasal swab, or saliva. To ensure the highest quality results, a nasopharyngeal swab is recommended. Specimen Preparation: Nasopharyngeal swab: Place in viral transport media Liquid Amies, or saline (minimum volume 1.2mL). Place each specimen in an individually sealed bag. Oropharyngeal or nasal swab: Place in viral transport media Liquid Amies, or saline (minimum volume 1.2mL). Swab Collection Kit. Place each specimen in an individually sealed bag. Saliva: Transport in COVID-19 Saliva Collection Tube Storage/Transport Temperature: Frozen. Unacceptable Conditions: Undiluted saliva. Saliva submitted in anything other than a Saliva Collection Tube. Swabs not in media. Wood swabs, calcium alginate swabs. Media with guanidine-containing materials, 'molecular media' that indicates inactivation of pathogens and preservation of RNA/DNA, charcoal media. Specimens sent in tubes with pop-top lids/caps. Specimens in glass tubes. Remarks: Stability: Swabs: Ambient: Unacceptable; Refrigerated: 2 days; Frozen: 1 month Saliva: Ambient: 5 days; Refrigerated: 5 days, Frozen: 5 days Reference Interval Interpretive Data This test should be ordered for the detection of the 2019 novel coronavirus SARS-CoV-2 in individuals who meet SARS-CoV-2 clinical and/or epidemiological criteria. The Coronavirus SARS-CoV-2 (COVID-19) by nucleic acid amplification test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for U.S. laboratories certified under CLIA to perform high complexity tests. Not Detected results do not rule out the presence of PCR inhibitors in the patient specimen or assay-specific nucleic acid in concentrations below the level of detection by the assay. Detected results are indicative of the presence of SARS-CoV-2 RNA. Due to the complexity of nucleic acid amplification methodologies, there may be a risk of false-positive results. Clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Reliable results are dependent on adequate specimen collection, transport, storage, and handling. Compliance Category: Depends on Specimen/Source/Method Note CPT Code 87635 Components Component Chart Name SARS-CoV-2 Source Component Test Code 3002639 LOINC 31208-2 3002640 SARS-CoV-2 by NAA 94500-6 Aliases 2019-nCoV Coronavirus disease - 2019 COVID-19 COVID-19 Illness COVID-2019 SARS-CoV-2

Ordering information regarding a Deamidated Gliadin Peptide (DGP) Antibody, IgG test for Clinical Diagnostic Laboratories. Deamidated Gliadin Peptide (DGP) Antibody, IgG Ordering Recommendation Acceptable single screening test for celiac disease. IgA testing recommended to identify IgA deficiency. Use IgG test in individuals who are IgA deficient. May be useful in diagnosing children <2 years who test negative for tTG and EMA antibodies. May aid in monitoring adherence to gluten-free diet. Celiac Disease Reflexive Cascade (2008114 ) or Tissue Transglutaminase (tTG) Antibody, IgG (0056009 ) is the preferred test for screening patients with suspected celiac disease. Mnemonic Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Performed Mon-Sat Reported 1-2 Days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transport 0.5 mL serum. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Plasma or other body fluids. Contaminated, hemolyzed, grossly icteric, or grossly lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year Reference Interval 19 Units or less 20-30 Units Negative Weak Positive 31 Units or greater Positive Interpretive Data Note CPT Code 86258 Components Component Chart Name Deamidated Gliadin Peptide (DGP) Ab, IgG Component Test Code 0051359 LOINC 63459-2 Aliases Celiac Disease Antibodies Deamidated Gliadin Antibodies (DGP) Deaminated Gliadin Peptide Antibodies DGP DGP Ab DGP IgA

Ordering information regarding a Comprehensive Metabolic Panel test for Clinical Diagnostic Laboratories. Comprehensive Metabolic Panel Ordering Recommendation Mnemonic Methodology Quantitative Ion-Selective Electrode/Quantitative Enzymatic Assay/Quantitative Spectrophotometry Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Protect from light. Allow serum tube to clot completely at room temperature. Separate serum or plasma from cells ASAP or within 30 minutes of collection. Transfer 1 mL serum or plasma to an Amber Transport Tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: EDTA, citrate, oxalate, or sodium fluoride/potassium oxalate. Remarks: Stability: After separation from cells: Ambient: Calcium and CO2: 4 hours, All others: 24 hours; Refrigerated: 1 week; Frozen: 2 weeksated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval 19 Units or less 20-39 Units Negative Weak Positive 40-59 Units Moderate Positive 60 Units or Greater Strong Positive Interpretive Data Note Tests included in this panel: Albumin, Serum or Plasma (0020030), Alkaline Phosphatase, Serum or Plasma (0020005), Aspartate Aminotransferase, Serum or Plasma (0020007), Alanine Aminotransferase, Serum or Plasma (0020008), Bilirubin, Total, Serum or Plasma (0020032), Calcium, Serum or Plasma (0020027), Carbon Dioxide, Serum or Plasma (0020004), Creatinine, Serum or Plasma (0020025), Chloride, Serum or Plasma (0020003), Glucose, Serum or Plasma (0020024), Potassium, Plasma or Serum (0020002), Protein, Total, Plasma or Serum (0020029), Sodium, Plasma or Serum (0020001), and Urea Nitrogen, Plasma or Serum (0020023). CPT Code 80053 Components Component Chart Name Component Test Code LOINC Sodium, Serum or Plasma 0020001 2951-2 0020002 Potassium, Serum or Plasma 2823-3 0020003 0020004 Chloride, Serum or Plasma 2075-0 Carbon Dioxide, Serum or Plasma 2028-9 0020005 0020007 Alkaline Phosphatase 6768-6 Aspartate Aminotransferase 1920-8 0020008 0020023 Alanine Aminotransferase 1742-6 Urea Nitrogen, Serum or Plasma 0020024 0020025 3094-0 Glucose, Serum or Plasma Creatinine, Serum or Plasma 2345-7 2160-0 0020027 0020029 Calcium, Serum or Plasma Protein Total, Serum/Plasma 17861-6 2885-2 0020030 0020032 Albumin, Serum or Plasma Bilirubin, Total, Serum or Plasma 1751-7 1975-2 0020396 3004293 Anion Gap UH EGFR 33037-3 Aliases ACPA Antibody Anti Citrulline Anti-CCP C12 Chem 12 Chemistry Panel Chemistry Screen CMP SMA 12 SMA 20 SMAC

We Provide Services for a Wide Variety of Companies and Organizations At our Medical Laboratory, we offer comprehensive services for companies and organizations. We provide a wide variety of medical testing, including drug screening for new employees, blood tests, and COVID or FLU testing for travel purposes. Our highly experienced team is capable of accommodating large groups efficiently and effectively. Contact us today for more information Contact Us Learn More Learn More Learn More Learn More Services for Life Insurance Companies Learn More Services for Government Agencies Learn More Services for Employer Solutions Learn More Services for Employer Solutions Learn More

Ordering information regarding a Serine Proteinase 3 (PR3) Antibody for Clinical Diagnostic Laboratories. Serine Proteinase 3 (PR3) Antibody Ordering Recommendation When used in conjunction with other autoantibody tests (ANCA, MPO), may aid in differentiating suspected Wegener granulomatosis (WG) from other vasculitides. May be useful to monitor patients with PR3 antibodies. Panel tests are available. For the workup of suspected vasculitis, refer to ANCA-Associated Vasculitis Profile (ANCA/MPO/PR3) (3003745 ). For patients with a history of vasculitis, refer to Myeloperoxidase (MPO) Antibody and Serine Proteinase 3 (PR3) Antibody with Reflex to Anti-Neutrophil Cytoplasmic Antibody, IgG by IFA (3003746 ). Mnemonic PR3 Performed Mon-Sat Methodology Semi-Quantitative Multiplex Bead Assay Reported 1-2 Days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.2 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma, urine, or other body fluids. Contaminated, hemolyzed, or severely lipemic specimens., icteric, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval 19 AU/mL or less Negative 20-25 AU/mL 26 AU/mL or greater Equivocal Positive Interpretive Data Approximately 85% of patients with a C-ANCA pattern by IFA have antibodies specific for PR3. Compliance Category: FDA Note CPT Code 83516 Components Component Chart Name Serine Proteinase 3 (PR3) Ab, IgG Component Test Code 0050527 LOINC 6968-2 Aliases PR3 PR3 Ab PR3 IgG Antibodies

Services for Organizations and Employers Available for All of Your Testing Needs! At our Medical Laboratory, we understand that testing your new employees might be difficult. We have you covered with our wide variety of comprehensive testing services, including COVID, Flu, Urine Drug Screenings, and much more. We make receiving results fast, efficient, and easy, so you can quickly and confidently move forward with your employee onboarding process. As a private lab, we strive to make the process of testing your employees fast, efficient, and easy. In order to provide the highest level of service to patients, organizations, and physicians we work with, we go the extra mile to make sure you have the results you need quickly and simply. For any questions or more information, contact us using the button below. CONTACT US

Ordering information regarding a ​Rheumatoid Factor (RF) for Clinical Diagnostic Laboratories. Rheumatoid Factor (RF) Ordering Recommendation Aids in the workup of suspected rheumatoid arthritis or undifferentiated inflammatory arthritides. Consider ordering this test in conjunction with Cyclic Citrullinated Peptide (CCP) Antibody, IgG (0055256 ) to increase specificity and sensitivity. Rheumatoid Arthritis Panel (3004055 ) is the preferred test. Mnemonic Methodology Quantitative Immunoturbidimetry Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Fasting specimen preferred. Collect: Serum separator tube or plasma separator tube. Also acceptable: Green (lithium heparin), lavender or pink. Specimen Preparation: Allow the specimen to clot completely at room temperature. Transfer 0.5 mL serum or plasma to a Standard Transport Tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Plasma or other body fluids. Contaminated, hemolyzed, grossly icteric, or grossly lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 24 hours; Refrigerated: 8 days; Frozen: 3 months (should not be thawed more than once) Reference Interval 0-14 IU/mL Interpretive Data Note CPT Code 86431 Components Component Chart Name Rheumatoid Factor Component Test Code 0050465 LOINC 11572-5 Aliases RA RF Rheumatoid Arthritis Factor

The product page for the general Women's Health Panel Clinical Diagnostic Laboratories. Women's Health Panel Feel your best, inside and out. This comprehensive blood panel is designed specifically for women to provide a clear picture of your overall health, hormone balance, and essential nutrients. Whether you’re managing symptoms, staying proactive, or just checking in — this panel helps you take control of your wellness. Here’s what it checks — and why it matters: Complete Blood Count (CBC) – Measures your white and red blood cells to check for signs of fatigue, infection, or anemia. Comprehensive Metabolic Panel (CMP) – Evaluates your liver and kidney function, blood sugar, and electrolyte balance. Lipid Panel – Assesses cholesterol levels, including “good” (HDL) and “bad” (LDL) cholesterol, to help understand your heart health. TSH (Thyroid-Stimulating Hormone) – Screens for thyroid issues that can affect weight, mood, and energy. T4, Total & T3, Free – Additional thyroid hormones that give a fuller view of thyroid function and metabolic health. Estradiol, LH, FSH – These hormones play a major role in reproductive health, menstrual cycles, fertility, and symptoms like hot flashes or irregular periods. Vitamin D – Checks for deficiency in this key vitamin that supports your bones, immune health, and mood. Ferritin – Measures iron storage in the body, which can help explain fatigue, hair thinning, or low energy. One blood draw — no referrals, no insurance required. Just clear answers, fast results, and the confidence to take control of your health. $263.50 Taxes will be calculated at checkout Buy Now

Ordering information regarding a Cardiolipin Antibody, IgG test for Clinical Diagnostic Laboratories. Cardiolipin Antibody, IgG Ordering Recommendation Acceptable initial test when antiphospholipid syndrome (APS) is strongly suspected. Order with Lupus Anticoagulant Reflexive Panel (0030181 ) and Beta-2 Glycoprotein 1 Antibodies, IgG and IgM (0050321 ). Cardiolipin Antibodies, IgG and IgM (0099344 ) is preferred. Mnemonic AC-IGG Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma or other body fluids. Contaminated, heat-inactivated, hemolyzed, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year Reference Interval <=14 GPL Negative 15-19 GPL Indeterminate 20-80 GPL Low to Moderately Positive 81 GPL or above High Positive Interpretive Data Anti-mitochondrial antibodies (AMA) are thought to be present in 90-95% of patients with primary biliary cholangitis (PBC). However, the frequency of detected antibodies may be cohort or assay dependent, as lower sensitivities have been reported. Not all PBC patients are positive for AMA; some patients may be positive for SP100 and/or GP210 antibodies. A negative result does not rule out PBC. Compliance Category: FDA Note CPT Code 86381 Components Component Chart Name Cardiolipin Antibody IgG Component Test Code 0050901 LOINC 3181-5 Aliases ACA aCL aCL Antibody aCL IgG Anti-Cardiolipin Anticardiolipin Anticardiolipin Antibodies Cardiolip